GO
Loading...

Is this the next pharma M&A target?

Wednesday, 4 Jun 2014 | 12:35 AM ET

CNBC's Catherine Boyle discusses why U.K.-listed drugmaker Shire is in the spotlight as a possible takeover target in the pharmaceutical sector.